 Laura Fenton
Concepts (337)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Stem Neoplasms | 5 | 2015 | 89 | 0.870 |
Why?
| | Magnetic Resonance Imaging | 19 | 2024 | 3169 | 0.800 |
Why?
| | Tomography, X-Ray Computed | 9 | 2014 | 2433 | 0.760 |
Why?
| | Neuroimaging | 1 | 2022 | 256 | 0.740 |
Why?
| | Brain | 6 | 2022 | 2481 | 0.670 |
Why?
| | Ganglioglioma | 2 | 2015 | 35 | 0.610 |
Why?
| | Esophagus | 3 | 2015 | 237 | 0.600 |
Why?
| | Wounds, Nonpenetrating | 3 | 2016 | 279 | 0.590 |
Why?
| | Scrotum | 1 | 2016 | 25 | 0.560 |
Why?
| | Diagnostic Techniques, Digestive System | 1 | 2015 | 10 | 0.550 |
Why?
| | Eosinophilic Esophagitis | 2 | 2020 | 308 | 0.540 |
Why?
| | Esophageal Stenosis | 1 | 2015 | 47 | 0.520 |
Why?
| | Brain Diseases | 2 | 2019 | 141 | 0.520 |
Why?
| | Infratentorial Neoplasms | 1 | 2014 | 49 | 0.470 |
Why?
| | Eosinophils | 1 | 2015 | 282 | 0.460 |
Why?
| | Osteitis | 1 | 2013 | 3 | 0.460 |
Why?
| | Child | 33 | 2024 | 19033 | 0.450 |
Why?
| | Glioma | 2 | 2009 | 302 | 0.450 |
Why?
| | Ultrasonography | 3 | 2016 | 714 | 0.440 |
Why?
| | Positron-Emission Tomography | 2 | 2019 | 298 | 0.430 |
Why?
| | Child, Preschool | 23 | 2019 | 9448 | 0.430 |
Why?
| | Prosthesis-Related Infections | 1 | 2013 | 74 | 0.420 |
Why?
| | Gastritis | 1 | 2013 | 81 | 0.420 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2014 | 202 | 0.420 |
Why?
| | Enteritis | 1 | 2013 | 78 | 0.420 |
Why?
| | Urea Cycle Disorders, Inborn | 1 | 2011 | 22 | 0.410 |
Why?
| | Eosinophilia | 1 | 2013 | 185 | 0.390 |
Why?
| | Radiography | 8 | 2016 | 860 | 0.380 |
Why?
| | Colitis | 1 | 2013 | 219 | 0.370 |
Why?
| | Radiation Injuries | 2 | 2019 | 131 | 0.370 |
Why?
| | Infant | 20 | 2019 | 8254 | 0.370 |
Why?
| | Spinal Fusion | 1 | 2013 | 225 | 0.360 |
Why?
| | Nervous System Diseases | 1 | 2011 | 261 | 0.330 |
Why?
| | Male | 39 | 2019 | 57474 | 0.300 |
Why?
| | Pamphlets | 1 | 2007 | 24 | 0.300 |
Why?
| | Adolescent | 24 | 2019 | 18364 | 0.300 |
Why?
| | Mutation | 3 | 2014 | 3435 | 0.300 |
Why?
| | Sensitivity and Specificity | 4 | 2013 | 1787 | 0.300 |
Why?
| | Female | 44 | 2019 | 61261 | 0.290 |
Why?
| | Astrocytoma | 2 | 2007 | 112 | 0.290 |
Why?
| | Deglutition Disorders | 2 | 2020 | 128 | 0.290 |
Why?
| | Infant, Newborn | 16 | 2019 | 5230 | 0.280 |
Why?
| | Radiation Dosage | 1 | 2007 | 147 | 0.280 |
Why?
| | Humans | 56 | 2024 | 118251 | 0.280 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2008 | 227 | 0.280 |
Why?
| | Reproducibility of Results | 6 | 2015 | 2855 | 0.280 |
Why?
| | Brain Neoplasms | 3 | 2012 | 1019 | 0.280 |
Why?
| | Liver Neoplasms | 2 | 2008 | 526 | 0.270 |
Why?
| | Diagnosis, Differential | 7 | 2013 | 1379 | 0.270 |
Why?
| | Stroke | 3 | 2022 | 1046 | 0.270 |
Why?
| | Vertebral Artery Dissection | 2 | 2022 | 19 | 0.260 |
Why?
| | Retrospective Studies | 14 | 2024 | 12929 | 0.250 |
Why?
| | Ascorbic Acid Deficiency | 1 | 2024 | 6 | 0.240 |
Why?
| | Scurvy | 1 | 2024 | 12 | 0.240 |
Why?
| | Venous Thrombosis | 2 | 2016 | 145 | 0.240 |
Why?
| | Tomography, Emission-Computed | 1 | 2003 | 58 | 0.230 |
Why?
| | Encephalocele | 1 | 2022 | 7 | 0.220 |
Why?
| | Neuroblastoma | 2 | 2010 | 135 | 0.220 |
Why?
| | Cerebral Cortex | 2 | 2019 | 415 | 0.220 |
Why?
| | Brain Stem | 1 | 2003 | 104 | 0.210 |
Why?
| | Teratoma | 1 | 2003 | 92 | 0.210 |
Why?
| | Rhabdoid Tumor | 1 | 2003 | 80 | 0.210 |
Why?
| | Diagnostic Errors | 1 | 2003 | 162 | 0.210 |
Why?
| | Child Abuse | 2 | 2012 | 465 | 0.200 |
Why?
| | Parietal Bone | 1 | 2000 | 12 | 0.200 |
Why?
| | Intracranial Aneurysm | 1 | 2022 | 99 | 0.200 |
Why?
| | Connective Tissue | 1 | 2000 | 37 | 0.190 |
Why?
| | Skull Fractures | 1 | 2000 | 30 | 0.190 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2000 | 19 | 0.190 |
Why?
| | Vitelline Duct | 1 | 2000 | 1 | 0.190 |
Why?
| | Intracranial Hemorrhages | 1 | 2000 | 77 | 0.180 |
Why?
| | Prognosis | 5 | 2014 | 3424 | 0.180 |
Why?
| | Radiotherapy | 2 | 2019 | 187 | 0.180 |
Why?
| | Intestinal Obstruction | 1 | 2000 | 41 | 0.180 |
Why?
| | Parents | 1 | 2007 | 1208 | 0.170 |
Why?
| | Intestine, Small | 1 | 2000 | 130 | 0.170 |
Why?
| | Bevacizumab | 1 | 2019 | 123 | 0.170 |
Why?
| | Corpus Callosum | 1 | 2019 | 57 | 0.170 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2007 | 1183 | 0.170 |
Why?
| | Hyperglycinemia, Nonketotic | 1 | 2019 | 46 | 0.170 |
Why?
| | Esophagoscopy | 2 | 2020 | 190 | 0.160 |
Why?
| | tau Proteins | 1 | 2019 | 78 | 0.160 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2003 | 1385 | 0.160 |
Why?
| | Fluorodeoxyglucose F18 | 2 | 2013 | 131 | 0.160 |
Why?
| | Disease-Free Survival | 2 | 2014 | 649 | 0.160 |
Why?
| | Fatty Liver | 2 | 2012 | 247 | 0.160 |
Why?
| | Magnetic Resonance Angiography | 1 | 2019 | 210 | 0.160 |
Why?
| | Young Adult | 6 | 2015 | 10731 | 0.160 |
Why?
| | Radiopharmaceuticals | 2 | 2013 | 194 | 0.160 |
Why?
| | Fatal Outcome | 4 | 2016 | 286 | 0.150 |
Why?
| | Central Nervous System Neoplasms | 1 | 2019 | 128 | 0.150 |
Why?
| | Angiogenesis Inhibitors | 1 | 2019 | 218 | 0.150 |
Why?
| | Smith-Magenis Syndrome | 1 | 2017 | 2 | 0.150 |
Why?
| | Treatment Outcome | 8 | 2014 | 9319 | 0.150 |
Why?
| | Moyamoya Disease | 1 | 2017 | 15 | 0.150 |
Why?
| | White Matter | 1 | 2019 | 115 | 0.150 |
Why?
| | Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2016 | 6 | 0.150 |
Why?
| | Multimodal Imaging | 2 | 2019 | 100 | 0.150 |
Why?
| | Bronchopulmonary Sequestration | 1 | 1996 | 8 | 0.150 |
Why?
| | Hyperammonemia | 1 | 2016 | 15 | 0.150 |
Why?
| | Leigh Disease | 2 | 2013 | 17 | 0.140 |
Why?
| | Stomach | 1 | 1996 | 103 | 0.140 |
Why?
| | Intracranial Thrombosis | 1 | 2016 | 17 | 0.140 |
Why?
| | Brain Infarction | 1 | 2016 | 23 | 0.140 |
Why?
| | Vascular Malformations | 1 | 2016 | 47 | 0.140 |
Why?
| | Cerebral Veins | 1 | 2016 | 16 | 0.140 |
Why?
| | Portal Vein | 1 | 2016 | 90 | 0.140 |
Why?
| | Contrast Media | 3 | 2019 | 373 | 0.140 |
Why?
| | Supratentorial Neoplasms | 1 | 2015 | 19 | 0.140 |
Why?
| | Cavernous Sinus Thrombosis | 1 | 2015 | 9 | 0.130 |
Why?
| | Adrenal Gland Neoplasms | 1 | 1996 | 81 | 0.130 |
Why?
| | DNA Mutational Analysis | 2 | 2014 | 379 | 0.130 |
Why?
| | Neurosurgical Procedures | 1 | 2017 | 164 | 0.130 |
Why?
| | Cerebral Infarction | 1 | 2015 | 45 | 0.130 |
Why?
| | Abdominal Pain | 2 | 2011 | 133 | 0.130 |
Why?
| | Temporal Lobe | 1 | 2015 | 90 | 0.130 |
Why?
| | Fibrin Fibrinogen Degradation Products | 2 | 2012 | 78 | 0.130 |
Why?
| | Lymphangiectasis | 1 | 2014 | 4 | 0.130 |
Why?
| | Carotid Stenosis | 1 | 2015 | 75 | 0.130 |
Why?
| | Lymphangiectasis, Intestinal | 1 | 2014 | 7 | 0.130 |
Why?
| | Spasm | 1 | 2013 | 19 | 0.120 |
Why?
| | Metal Metabolism, Inborn Errors | 1 | 2012 | 5 | 0.110 |
Why?
| | Alzheimer Disease | 1 | 2019 | 512 | 0.110 |
Why?
| | Cerebral Arterial Diseases | 1 | 2012 | 43 | 0.110 |
Why?
| | Neuroectodermal Tumors, Primitive | 1 | 2012 | 13 | 0.110 |
Why?
| | Pons | 1 | 2012 | 31 | 0.110 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2012 | 90 | 0.110 |
Why?
| | DNA, Mitochondrial | 1 | 2013 | 187 | 0.110 |
Why?
| | Athletic Injuries | 2 | 2016 | 476 | 0.110 |
Why?
| | Accidents | 1 | 2012 | 44 | 0.100 |
Why?
| | Splenomegaly | 1 | 2011 | 16 | 0.100 |
Why?
| | Craniotomy | 1 | 2012 | 69 | 0.100 |
Why?
| | Hemoglobin SC Disease | 1 | 2011 | 14 | 0.100 |
Why?
| | Necrosis | 3 | 2019 | 230 | 0.100 |
Why?
| | Decompression, Surgical | 1 | 2012 | 97 | 0.100 |
Why?
| | Anticoagulants | 1 | 2015 | 555 | 0.100 |
Why?
| | Blood Coagulation Disorders | 1 | 2012 | 166 | 0.100 |
Why?
| | Succinate-CoA Ligases | 1 | 2010 | 4 | 0.100 |
Why?
| | Brain Diseases, Metabolic | 1 | 2010 | 7 | 0.100 |
Why?
| | Liver Diseases | 2 | 2010 | 282 | 0.090 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2012 | 505 | 0.090 |
Why?
| | Fibrinolytic Agents | 1 | 2012 | 233 | 0.090 |
Why?
| | Scoliosis | 1 | 2013 | 183 | 0.090 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2010 | 65 | 0.090 |
Why?
| | Recurrence | 3 | 2022 | 971 | 0.090 |
Why?
| | Mitochondrial Diseases | 1 | 2010 | 79 | 0.090 |
Why?
| | Incidental Findings | 1 | 2010 | 80 | 0.090 |
Why?
| | Thrombophilia | 1 | 2009 | 62 | 0.090 |
Why?
| | Lymphoproliferative Disorders | 1 | 2009 | 46 | 0.090 |
Why?
| | Optic Neuritis | 1 | 2009 | 37 | 0.090 |
Why?
| | Liver | 2 | 2016 | 1803 | 0.080 |
Why?
| | Facial Injuries | 1 | 2009 | 19 | 0.080 |
Why?
| | Cerebellar Neoplasms | 1 | 2010 | 135 | 0.080 |
Why?
| | Autopsy | 2 | 2016 | 89 | 0.080 |
Why?
| | Facial Bones | 1 | 2009 | 33 | 0.080 |
Why?
| | Aging | 1 | 2019 | 1675 | 0.080 |
Why?
| | Chromosomes, Human, Y | 1 | 2008 | 15 | 0.080 |
Why?
| | Diabetes, Gestational | 1 | 2012 | 284 | 0.080 |
Why?
| | Medulloblastoma | 1 | 2010 | 177 | 0.080 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2009 | 73 | 0.080 |
Why?
| | Prenatal Diagnosis | 1 | 2010 | 167 | 0.080 |
Why?
| | Chromosomes, Human, X | 1 | 2008 | 58 | 0.080 |
Why?
| | Craniopharyngioma | 1 | 2009 | 70 | 0.080 |
Why?
| | Sex Chromosome Aberrations | 1 | 2008 | 53 | 0.080 |
Why?
| | Meningomyelocele | 1 | 2008 | 51 | 0.080 |
Why?
| | Biopsy | 2 | 2010 | 1078 | 0.080 |
Why?
| | Lung Diseases | 1 | 2014 | 709 | 0.080 |
Why?
| | Glioblastoma | 1 | 2010 | 263 | 0.080 |
Why?
| | Aneuploidy | 1 | 2008 | 88 | 0.080 |
Why?
| | Ultrasonography, Doppler | 1 | 2008 | 104 | 0.080 |
Why?
| | Adult | 8 | 2019 | 31324 | 0.080 |
Why?
| | Obesity | 2 | 2012 | 2715 | 0.080 |
Why?
| | Brain Injuries | 1 | 2012 | 479 | 0.070 |
Why?
| | Glucose Tolerance Test | 1 | 2008 | 361 | 0.070 |
Why?
| | Abnormalities, Multiple | 1 | 2008 | 182 | 0.070 |
Why?
| | Brain Ischemia | 1 | 2009 | 309 | 0.070 |
Why?
| | Carotid Artery Thrombosis | 1 | 2005 | 8 | 0.070 |
Why?
| | Mucormycosis | 1 | 2005 | 20 | 0.070 |
Why?
| | Vascular Diseases | 1 | 2009 | 241 | 0.070 |
Why?
| | Osteoporosis | 1 | 2008 | 226 | 0.070 |
Why?
| | Developmental Disabilities | 1 | 2008 | 245 | 0.070 |
Why?
| | Bone Density | 1 | 2008 | 447 | 0.060 |
Why?
| | Feasibility Studies | 2 | 2019 | 746 | 0.060 |
Why?
| | Follow-Up Studies | 4 | 2016 | 4574 | 0.060 |
Why?
| | Metabolic Syndrome | 1 | 2008 | 392 | 0.060 |
Why?
| | Vincristine | 1 | 2003 | 99 | 0.060 |
Why?
| | Sinusitis | 1 | 2005 | 175 | 0.060 |
Why?
| | Risk Factors | 5 | 2012 | 8958 | 0.060 |
Why?
| | Carboplatin | 1 | 2003 | 140 | 0.060 |
Why?
| | Ascorbic Acid | 1 | 2024 | 120 | 0.060 |
Why?
| | Hernia, Hiatal | 1 | 2003 | 34 | 0.060 |
Why?
| | Pancreatic Neoplasms | 1 | 2010 | 727 | 0.060 |
Why?
| | Pilot Projects | 2 | 2019 | 1405 | 0.060 |
Why?
| | Hemangioendothelioma | 1 | 2002 | 13 | 0.050 |
Why?
| | Vertebral Artery | 1 | 2022 | 27 | 0.050 |
Why?
| | Ultrasonography, Prenatal | 2 | 2010 | 227 | 0.050 |
Why?
| | Colorado | 4 | 2015 | 4178 | 0.050 |
Why?
| | Liver Transplantation | 1 | 2009 | 843 | 0.050 |
Why?
| | Spinal Cord Neoplasms | 1 | 2001 | 42 | 0.050 |
Why?
| | Cross-Sectional Studies | 4 | 2019 | 4521 | 0.050 |
Why?
| | Vitamin K Deficiency | 1 | 2000 | 9 | 0.050 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2000 | 29 | 0.050 |
Why?
| | Dilatation | 1 | 2020 | 56 | 0.050 |
Why?
| | Mental Disorders | 1 | 2008 | 935 | 0.050 |
Why?
| | Enema | 1 | 2000 | 39 | 0.050 |
Why?
| | Herpes Simplex | 1 | 2000 | 90 | 0.050 |
Why?
| | Diseases in Twins | 1 | 2000 | 181 | 0.040 |
Why?
| | Carotid Artery Diseases | 1 | 2019 | 58 | 0.040 |
Why?
| | Neck | 1 | 2019 | 89 | 0.040 |
Why?
| | Biomarkers | 1 | 2009 | 3567 | 0.040 |
Why?
| | Ependymoma | 1 | 2001 | 165 | 0.040 |
Why?
| | Carbolines | 1 | 2019 | 29 | 0.040 |
Why?
| | Inflammation | 1 | 2009 | 2545 | 0.040 |
Why?
| | Aniline Compounds | 1 | 2019 | 70 | 0.040 |
Why?
| | Spectrum Analysis | 1 | 2019 | 88 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2003 | 1857 | 0.040 |
Why?
| | Pregnancy | 5 | 2012 | 5671 | 0.040 |
Why?
| | Atrophy | 1 | 2019 | 164 | 0.040 |
Why?
| | Thiazoles | 1 | 2019 | 121 | 0.040 |
Why?
| | Cohort Studies | 3 | 2016 | 5078 | 0.040 |
Why?
| | Organ Size | 1 | 2019 | 460 | 0.040 |
Why?
| | Gastroepiploic Artery | 1 | 2017 | 4 | 0.040 |
Why?
| | Dexamethasone | 1 | 2019 | 319 | 0.040 |
Why?
| | Cerebral Revascularization | 1 | 2017 | 15 | 0.040 |
Why?
| | Phenotype | 2 | 2019 | 2937 | 0.040 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2016 | 35 | 0.040 |
Why?
| | Cerebral Angiography | 1 | 2017 | 116 | 0.040 |
Why?
| | Acidosis, Lactic | 1 | 2016 | 29 | 0.040 |
Why?
| | Imaging, Three-Dimensional | 1 | 2019 | 500 | 0.030 |
Why?
| | Congenital Abnormalities | 1 | 1996 | 72 | 0.030 |
Why?
| | Intellectual Disability | 1 | 2017 | 136 | 0.030 |
Why?
| | Florida | 1 | 2015 | 73 | 0.030 |
Why?
| | Endpoint Determination | 1 | 2015 | 69 | 0.030 |
Why?
| | Glucocorticoids | 1 | 2019 | 545 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2015 | 269 | 0.030 |
Why?
| | Observer Variation | 1 | 2015 | 306 | 0.030 |
Why?
| | Combined Modality Therapy | 2 | 2009 | 1163 | 0.030 |
Why?
| | Hemorrhage | 2 | 2015 | 606 | 0.030 |
Why?
| | Molybdoferredoxin | 1 | 2012 | 13 | 0.030 |
Why?
| | Quality Assurance, Health Care | 1 | 2015 | 324 | 0.030 |
Why?
| | Diagnostic Imaging | 1 | 2015 | 294 | 0.030 |
Why?
| | Erythroblastosis, Fetal | 1 | 1972 | 3 | 0.030 |
Why?
| | Persistent Vegetative State | 1 | 2012 | 4 | 0.030 |
Why?
| | Pedigree | 1 | 2013 | 485 | 0.030 |
Why?
| | Time Factors | 2 | 2015 | 6368 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2019 | 2491 | 0.030 |
Why?
| | Middle Aged | 3 | 2019 | 27510 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2019 | 3156 | 0.020 |
Why?
| | Glasgow Coma Scale | 1 | 2012 | 146 | 0.020 |
Why?
| | Splenectomy | 1 | 2011 | 56 | 0.020 |
Why?
| | Disabled Children | 1 | 2012 | 68 | 0.020 |
Why?
| | Aged | 2 | 2019 | 19594 | 0.020 |
Why?
| | Karyotyping | 1 | 2010 | 102 | 0.020 |
Why?
| | Accidents, Traffic | 1 | 2012 | 176 | 0.020 |
Why?
| | Anemia | 1 | 1972 | 145 | 0.020 |
Why?
| | Factor VIII | 1 | 2009 | 55 | 0.020 |
Why?
| | Biopsy, Needle | 1 | 2010 | 188 | 0.020 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2005 | 3358 | 0.020 |
Why?
| | Rare Diseases | 1 | 2010 | 93 | 0.020 |
Why?
| | Optic Nerve | 1 | 2009 | 65 | 0.020 |
Why?
| | Research Design | 1 | 2015 | 961 | 0.020 |
Why?
| | Fractures, Spontaneous | 1 | 2008 | 14 | 0.020 |
Why?
| | Wheelchairs | 1 | 2008 | 16 | 0.020 |
Why?
| | Fetal Diseases | 1 | 2010 | 148 | 0.020 |
Why?
| | Body Composition | 1 | 2012 | 644 | 0.020 |
Why?
| | Cesarean Section | 1 | 2010 | 165 | 0.020 |
Why?
| | Calcium, Dietary | 1 | 2008 | 55 | 0.020 |
Why?
| | Gestational Age | 2 | 2010 | 765 | 0.020 |
Why?
| | Pancreatectomy | 1 | 2010 | 165 | 0.020 |
Why?
| | Neurologic Examination | 1 | 2008 | 126 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 764 | 0.020 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2010 | 317 | 0.020 |
Why?
| | Age of Onset | 1 | 2009 | 465 | 0.020 |
Why?
| | Mobility Limitation | 1 | 2008 | 62 | 0.020 |
Why?
| | Recovery of Function | 1 | 2012 | 603 | 0.020 |
Why?
| | Absorptiometry, Photon | 1 | 2008 | 226 | 0.020 |
Why?
| | Adiposity | 1 | 2012 | 508 | 0.020 |
Why?
| | C-Reactive Protein | 1 | 2009 | 364 | 0.020 |
Why?
| | Prenatal Care | 1 | 2010 | 252 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 6541 | 0.020 |
Why?
| | Syndrome | 1 | 2008 | 343 | 0.020 |
Why?
| | Bleomycin | 1 | 2009 | 228 | 0.020 |
Why?
| | Cholesterol, HDL | 1 | 2008 | 198 | 0.020 |
Why?
| | Base Sequence | 1 | 2010 | 2148 | 0.020 |
Why?
| | Survival Rate | 1 | 2010 | 1716 | 0.020 |
Why?
| | Mucor | 1 | 2005 | 7 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2010 | 2063 | 0.020 |
Why?
| | Cavernous Sinus | 1 | 2005 | 16 | 0.020 |
Why?
| | Telencephalon | 1 | 2005 | 16 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2010 | 1681 | 0.020 |
Why?
| | Triglycerides | 1 | 2008 | 515 | 0.020 |
Why?
| | Orbit | 1 | 2005 | 59 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2010 | 2855 | 0.020 |
Why?
| | Paranasal Sinuses | 1 | 2005 | 64 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2010 | 1161 | 0.020 |
Why?
| | Prospective Studies | 2 | 2009 | 6443 | 0.010 |
Why?
| | Incidence | 1 | 2009 | 2413 | 0.010 |
Why?
| | United States | 1 | 2019 | 12488 | 0.010 |
Why?
| | Cleft Lip | 1 | 2003 | 33 | 0.010 |
Why?
| | Cleft Palate | 1 | 2003 | 48 | 0.010 |
Why?
| | Estrogen Receptor Modulators | 1 | 2001 | 19 | 0.010 |
Why?
| | Laminectomy | 1 | 2001 | 26 | 0.010 |
Why?
| | Etoposide | 1 | 2001 | 149 | 0.010 |
Why?
| | Blood Pressure | 1 | 2008 | 1656 | 0.010 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2001 | 189 | 0.010 |
Why?
| | Risk Assessment | 1 | 2010 | 3043 | 0.010 |
Why?
| | Tamoxifen | 1 | 2001 | 198 | 0.010 |
Why?
| | Body Mass Index | 1 | 2008 | 2074 | 0.010 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2001 | 360 | 0.010 |
Why?
| | Low Back Pain | 1 | 2001 | 100 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1999 | 181 | 0.010 |
Why?
| | Blood Glucose | 1 | 2008 | 1936 | 0.010 |
Why?
| | Appendicitis | 1 | 1999 | 124 | 0.010 |
Why?
| | Acute Disease | 1 | 1999 | 933 | 0.010 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2001 | 895 | 0.010 |
Why?
| | Parathyroid Glands | 1 | 1975 | 9 | 0.010 |
Why?
| | Pregnancy in Diabetics | 1 | 1975 | 88 | 0.010 |
Why?
| | Infant, Newborn, Diseases | 1 | 1975 | 106 | 0.010 |
Why?
| | Kidney Cortex Necrosis | 1 | 1972 | 1 | 0.010 |
Why?
| | Splenic Rupture | 1 | 1972 | 5 | 0.010 |
Why?
| | Exchange Transfusion, Whole Blood | 1 | 1972 | 18 | 0.010 |
Why?
| | Hemoperitoneum | 1 | 1972 | 13 | 0.010 |
Why?
| | Brain Edema | 1 | 1972 | 61 | 0.010 |
Why?
| | Pancreatic Diseases | 1 | 1972 | 63 | 0.010 |
Why?
| | Pulmonary Edema | 1 | 1972 | 119 | 0.010 |
Why?
| | Cerebral Hemorrhage | 1 | 1972 | 100 | 0.010 |
Why?
| | Spleen | 1 | 1972 | 504 | 0.010 |
Why?
| | Pulmonary Alveoli | 1 | 1972 | 375 | 0.010 |
Why?
| | Emergency Service, Hospital | 1 | 1999 | 1848 | 0.000 |
Why?
| | Hypocalcemia | 1 | 1975 | 30 | 0.000 |
Why?
| | Blood | 1 | 1975 | 97 | 0.000 |
Why?
| | Umbilical Cord | 1 | 1975 | 84 | 0.000 |
Why?
| | Magnesium | 1 | 1975 | 150 | 0.000 |
Why?
| | Phosphorus | 1 | 1975 | 84 | 0.000 |
Why?
| | Parathyroid Hormone | 1 | 1975 | 99 | 0.000 |
Why?
| | Phosphates | 1 | 1975 | 166 | 0.000 |
Why?
| | Calcium | 1 | 1975 | 1151 | 0.000 |
Why?
|
|
Fenton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|